Bone Biologics Corporation (BBLG)
USD 0.86
(1.91%)
USD 0.86
(1.91%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.42 Million USD | -157.24% |
| 2022 | -3.66 Million USD | -232.75% |
| 2021 | -1.1 Million USD | -33.51% |
| 2020 | -825.01 Thousand USD | 66.29% |
| 2019 | -2.44 Million USD | 12.31% |
| 2018 | -2.79 Million USD | -6.26% |
| 2017 | -2.62 Million USD | 85.28% |
| 2016 | -17.84 Million USD | -48.79% |
| 2015 | -11.99 Million USD | -298.46% |
| 2014 | -3.01 Million USD | -348.02% |
| 2013 | -671.98 Thousand USD | -154143.87% |
| 2012 | -435.66 USD | 85.48% |
| 2011 | -3000.00 USD | 0.0% |
| 2010 | -3000.00 USD | 0.0% |
| 2009 | -3000.00 USD | 77.52% |
| 2008 | -13.34 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -903.54 Thousand USD | 22.11% |
| 2024 Q2 | -809.66 Thousand USD | 10.39% |
| 2023 Q1 | -3.14 Million USD | -144.24% |
| 2023 Q4 | -1.16 Million USD | 44.25% |
| 2023 Q3 | -2.08 Million USD | 31.55% |
| 2023 FY | -9.42 Million USD | -157.24% |
| 2023 Q2 | -3.03 Million USD | 3.42% |
| 2022 Q4 | -1.28 Million USD | -5.69% |
| 2022 Q2 | -469.3 Thousand USD | 28.51% |
| 2022 Q1 | -656.42 Thousand USD | -43.05% |
| 2022 FY | -3.66 Million USD | -232.75% |
| 2022 Q3 | -1.21 Million USD | -159.81% |
| 2021 Q2 | -231.88 Thousand USD | -28.16% |
| 2021 Q3 | -229.78 Thousand USD | 0.9% |
| 2021 Q4 | -458.88 Thousand USD | -99.7% |
| 2021 FY | -1.1 Million USD | -33.51% |
| 2021 Q1 | -180.92 Thousand USD | 12.36% |
| 2020 Q2 | -132.7 Thousand USD | 60.97% |
| 2020 Q4 | -206.43 Thousand USD | -41.56% |
| 2020 FY | -825.01 Thousand USD | 66.29% |
| 2020 Q1 | -340.05 Thousand USD | -22.48% |
| 2020 Q3 | -145.82 Thousand USD | -9.88% |
| 2019 Q3 | -301.31 Thousand USD | 55.64% |
| 2019 Q2 | -679.25 Thousand USD | 42.88% |
| 2019 Q1 | -1.18 Million USD | 4.0% |
| 2019 FY | -2.44 Million USD | 12.31% |
| 2019 Q4 | -277.62 Thousand USD | 7.86% |
| 2018 Q3 | 404.79 Thousand USD | 147.06% |
| 2018 FY | -2.79 Million USD | -6.26% |
| 2018 Q4 | -1.23 Million USD | -406.04% |
| 2018 Q2 | -860.15 Thousand USD | 21.57% |
| 2018 Q1 | -1.09 Million USD | 16.32% |
| 2017 Q1 | -2.16 Million USD | 31.27% |
| 2017 FY | -2.62 Million USD | 85.28% |
| 2017 Q4 | -1.31 Million USD | -15.9% |
| 2017 Q3 | -1.13 Million USD | -157.26% |
| 2017 Q2 | 1.97 Million USD | 191.43% |
| 2016 Q2 | -4.28 Million USD | 34.63% |
| 2016 FY | -17.84 Million USD | -48.79% |
| 2016 Q4 | -3.14 Million USD | 18.52% |
| 2016 Q1 | -6.56 Million USD | 13.61% |
| 2016 Q3 | -3.85 Million USD | 10.05% |
| 2015 Q4 | -7.59 Million USD | -155.81% |
| 2015 Q3 | -2.96 Million USD | -481.39% |
| 2015 Q2 | -510.57 Thousand USD | 44.71% |
| 2015 Q1 | -923.42 Thousand USD | -17.49% |
| 2015 FY | -11.99 Million USD | -298.46% |
| 2014 Q4 | -785.96 Thousand USD | 8.25% |
| 2014 FY | -3.01 Million USD | -348.02% |
| 2014 Q3 | -856.6 Thousand USD | -170.65% |
| 2014 Q2 | -316.49 Thousand USD | -82.14% |
| 2014 Q1 | -173.76 Thousand USD | 27.79% |
| 2013 FY | -671.98 Thousand USD | -154143.87% |
| 2013 Q3 | -119.18 Thousand USD | 43.61% |
| 2013 Q2 | -211.37 Thousand USD | -35.43% |
| 2013 Q4 | -240.64 Thousand USD | -101.9% |
| 2013 Q1 | -156.07 Thousand USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | -435.66 USD | 85.48% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | -3000.00 USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | -3000.00 USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | -3000.00 USD | 77.52% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 100.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | -13.34 Thousand USD | 0.0% |
| 2008 Q4 | -3000.00 USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 34.348% |
| Cerus Corporation | -30.05 Million USD | 68.628% |
| OrthoPediatrics Corp. | -25.76 Million USD | 63.408% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 11.232% |
| Talis Biomedical Corporation | -66.81 Million USD | 85.889% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 45.489% |
| Inogen, Inc. | -109.38 Million USD | 91.381% |
| Spectral AI, Inc. | -12.98 Million USD | 27.385% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 84.936% |
| CVRx, Inc. | -43.1 Million USD | 78.126% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -167.242% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 24.137% |
| Orthofix Medical Inc. | -139.11 Million USD | 93.222% |
| Venus Concept Inc. | -28.3 Million USD | 66.695% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 82.549% |
| Bioventus Inc. | -81.72 Million USD | 88.463% |
| BrainsWay Ltd. | -4.92 Million USD | -91.36% |
| Envoy Medical, Inc. | -18.37 Million USD | 48.678% |
| electroCore, Inc. | -18.8 Million USD | 49.863% |
| IceCure Medical Ltd | -15.57 Million USD | 39.469% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 80.553% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 45.4% |
| MaxCyte, Inc. | -48.29 Million USD | 80.479% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 21.137% |
| Nexalin Technology, Inc. | -5.69 Million USD | -65.516% |
| PAVmed Inc | -68.79 Million USD | 86.295% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 83.331% |
| RxSight, Inc. | -50.08 Million USD | 81.175% |
| Sight Sciences, Inc. | -57.27 Million USD | 83.538% |
| SI-BONE, Inc. | -46.93 Million USD | 79.91% |
| TELA Bio, Inc. | -44.07 Million USD | 78.609% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 82.589% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 81.667% |
| LivaNova PLC | -68.49 Million USD | 86.236% |
| 908 Devices Inc. | -42.75 Million USD | 77.95% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 94.563% |
| Nemaura Medical Inc. | -9.59 Million USD | 1.74% |
| NeuroPace, Inc. | -27.17 Million USD | 65.304% |
| LENSAR, Inc. | -12.22 Million USD | 22.902% |
| Apyx Medical Corporation | -17.25 Million USD | 45.372% |
| Cutera, Inc. | -156.23 Million USD | 93.965% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -9.58% |
| BioSig Technologies, Inc. | -28.51 Million USD | 66.932% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 89.242% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 57.996% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 108.454% |
| Axonics, Inc. | -26.05 Million USD | 63.817% |
| Outset Medical, Inc. | -169.77 Million USD | 94.446% |
| IRIDEX Corporation | -10 Million USD | 5.783% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 91.364% |
| IRadimed Corporation | 20.03 Million USD | 147.058% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -14.352% |
| INVO Bioscience, Inc. | -6.76 Million USD | -39.324% |
| Telesis Bio, Inc. | -35.15 Million USD | 73.177% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 165.794% |
| Varex Imaging Corporation | 32.1 Million USD | 129.372% |
| Quipt Home Medical Corp. | 3.91 Million USD | 340.579% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 22.292% |
| Pulmonx Corporation | -61.93 Million USD | 84.777% |
| Dynatronics Corporation | -2.27 Million USD | -314.787% |
| Modular Medical, Inc. | -17.52 Million USD | 46.213% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 35.595% |
| Semler Scientific, Inc. | 22.25 Million USD | 142.363% |
| InMode Ltd. | 195.66 Million USD | 104.819% |
| Bruker Corporation | 436.9 Million USD | 102.158% |
| Cytosorbents Corporation | -31.2 Million USD | 69.79% |
| DexCom, Inc. | 597.7 Million USD | 101.577% |
| Align Technology, Inc. | 643.33 Million USD | 101.466% |
| Viveve Medical, Inc. | -21.55 Million USD | 56.255% |
| ZimVie Inc. | -30.93 Million USD | 69.526% |
| Movano Inc. | -29.69 Million USD | 68.244% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 66.14% |
| Nexalin Technology, Inc. | -5.69 Million USD | -65.516% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -167.242% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 95.958% |
| Profound Medical Corp. | -28.61 Million USD | 67.052% |
| Insulet Corporation | 220 Million USD | 104.286% |
| enVVeno Medical Corporation | -25.23 Million USD | 62.642% |
| Surmodics, Inc. | -5.64 Million USD | -67.02% |
| iCAD, Inc. | -7.68 Million USD | -22.621% |
| Nuwellis, Inc. | -17.63 Million USD | 46.521% |
| Biotricity, Inc. | -8.82 Million USD | -6.797% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 92.467% |
| Aethlon Medical, Inc. | -12.63 Million USD | 25.389% |
| InspireMD, Inc. | -21.14 Million USD | 55.407% |
| PAVmed Inc. | -68.79 Million USD | 86.295% |
| BIOLASE, Inc. | -17.93 Million USD | 47.437% |
| Beyond Air, Inc. | -63 Million USD | 85.036% |
| FONAR Corporation | 16.53 Million USD | 157.019% |
| AxoGen, Inc. | -21.46 Million USD | 56.07% |
| Vivani Medical, Inc. | -26.96 Million USD | 65.035% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 152.26% |
| Inari Medical, Inc. | -14.03 Million USD | 32.809% |
| UFP Technologies, Inc. | 57.66 Million USD | 116.35% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -91.337% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -49.519% |
| Tenon Medical, Inc. | -15.72 Million USD | 40.05% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -26.148% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 77.923% |
| AdaptHealth Corp. | -598.4 Million USD | 98.424% |
| Sintx Technologies, Inc. | -13.35 Million USD | 29.418% |
| NanoVibronix, Inc. | -3.43 Million USD | -174.398% |
| Quanterix Corporation | -49.7 Million USD | 81.03% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 22.292% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -2368.142% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 97.181% |
| TransMedics Group, Inc. | -28.72 Million USD | 67.18% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 60.07% |
| NeuroMetrix, Inc. | -7.15 Million USD | -31.836% |
| Hyperfine, Inc. | -48.11 Million USD | 80.405% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 85.501% |
| Biomerica, Inc. | -6.36 Million USD | -48.081% |
| AVITA Medical, Inc. | -40.4 Million USD | 76.664% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 8.563% |
| Silk Road Medical, Inc | -59.27 Million USD | 84.093% |